Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The Swiss biopharmaceutical company’s shares jumped in after-hours trading after it said the FDA approved its Optune Pax product. on.wsj.com/4r6VQGU
https://on.wsj.com/4r6VQGU
2026-02-12T02:46:45.951Z